These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8101889)
21. DNA ploidy and S + G2M fraction (proliferative index) as prognostic determinants in human periampullary cancer. Jorba R; Jaurrieta E; Bernat R; Verdaguer J; Fabregat J; Fernandez-Cruz L Hepatogastroenterology; 1995; 42(5):740-7. PubMed ID: 8751244 [TBL] [Abstract][Full Text] [Related]
22. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma. Martin G; Halwani F; Shibata H; Meterissian S Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254 [TBL] [Abstract][Full Text] [Related]
23. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study. Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157 [TBL] [Abstract][Full Text] [Related]
24. DNA ploidy, S-phase fraction and cytomorphometry in relation to survival of human penile cancer. Yu DS; Chang SY; Ma CP Urol Int; 1992; 48(3):265-9. PubMed ID: 1589914 [TBL] [Abstract][Full Text] [Related]
25. Prognostic implications of DNA ploidy and cell-cycle analysis in pancreatic and periampullary carcinoma. Jorba R; Fernández-Cruz L Hepatogastroenterology; 1994 Oct; 41(5):507-8. PubMed ID: 7851864 [No Abstract] [Full Text] [Related]
26. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients. Pinto AE; André S; Soares J J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479 [TBL] [Abstract][Full Text] [Related]
28. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas. Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers. Ohyama S; Yonemura Y; Miyazaki I Cancer; 1990 Jan; 65(1):116-21. PubMed ID: 2293858 [TBL] [Abstract][Full Text] [Related]
30. Cancers of the papilla of vater: mutator phenotype is associated with good prognosis. Achille A; Biasi MO; Zamboni G; Bogina G; Iacono C; Talamini G; Capella G; Scarpa A Clin Cancer Res; 1997 Oct; 3(10):1841-7. PubMed ID: 9815572 [TBL] [Abstract][Full Text] [Related]
31. Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis. Scarpa A; Di Pace C; Talamini G; Falconi M; Lemoine NR; Iacono C; Achille A; Baron A; Zamboni G Gut; 2000 Jun; 46(6):842-8. PubMed ID: 10807898 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient. Haffty BG; Toth M; Flynn S; Fischer D; Carter D J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Beerman H; Kluin PM; Hermans J; van de Velde CJ; Cornelisse CJ Int J Cancer; 1990 Jan; 45(1):34-9. PubMed ID: 2298504 [TBL] [Abstract][Full Text] [Related]
34. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells. Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971 [TBL] [Abstract][Full Text] [Related]
35. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04. Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345 [TBL] [Abstract][Full Text] [Related]
36. Clinical value of serum CA19-9 as a prognostic factor for the ampulla of Vater carcinoma. Kurihara C; Yoshimi F; Sasaki K; Iijima T; Kawasaki H; Nagai H Hepatogastroenterology; 2013 Oct; 60(127):1588-91. PubMed ID: 23933785 [TBL] [Abstract][Full Text] [Related]
37. The significance of proliferating cell nuclear antigen (PCNA) expression in cancer of the ampulla of vater in terms of prognosis. Isozaki H; Okajima K; Ichinona T; Tanimura M; Morita S; Takada Y; Ishibashi T; Hara H Surg Today; 1994; 24(6):494-9. PubMed ID: 7919730 [TBL] [Abstract][Full Text] [Related]
38. DNA aneuploidy is an independent factor of poor prognosis in pancreatic and peripancreatic cancer. Sciallero S; Giaretti W; Geido E; Bonelli L; Zhankui L; Saccomanno S; Zeraschi E; Pugliese V Int J Pancreatol; 1993 Aug; 14(1):21-8. PubMed ID: 8409573 [TBL] [Abstract][Full Text] [Related]
39. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432 [TBL] [Abstract][Full Text] [Related]
40. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer. Shyr YM; Su CH; Li AF; Wu CW; Lui WY Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]